Montreal, September 23, 2013 – Dr. Daniel Sinnett joined the Research Advisory Group of the Canadian Partnership Against Cancer last spring. Its members come from all over Canada and represent various lines of research and expertise in oncology. This wide array of talent makes it possible to ensure the Canadian Partnership Against Cancer plays a strategic leadership role and receives guidance in its work.

As a researcher in pediatric oncogenetics and Head of the Viral and Immune Disorders and Cancers axis at the Sainte-Justine University Hospital Research Center, Dr. Daniel Sinnett will help to define new issues and ways of fighting cancer. He will also strive to bring pediatric oncology to the forefront of Canadian oncology issues and ensure the Sainte-Justine University Hospital Center is a major player in the cancer arena in Canada.

One of the Research Advisory Group’s recent mandates consisted of examining the funding landscape in pediatric oncology in Canada to provide the Canadian Partnership Against Cancer with an overview of the current situation in order to propose new and better-adapted funding mechanisms.

In addition to being a scientist, Dr. Sinnett is also a professor in the Departments of Pediatrics and Biochemistry at the Université de Montréal, Executive Director of the Sainte-Justine University Hospital Research Center, member and co-founder of the Robert-Cedergren Center for Bio-Informatics and Genomics and holder of the François-Karl Viau Research Chair in Pediatric Oncogenomics at the Université de Montréal. His interests focus on the genetic and molecular mechanisms that underlie childhood leukemia.

Dr. Sinnett’s research work benefits from the financial support of the Fonds de recherche du Québec – Santé (FRQS), of the Canadian Institutes of Health Resarch (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Cancer Society Research Institute (CCSRI) and the Research Chair François-Karl Viau in pediatric oncogenomics.